Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab
Pharmacy Times
MAY 3, 2024
The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.
world spain 
Almirall, the first to assess wellbeing in a dermatology clinical study
Pharmafile
APRIL 12, 2023
April 12, 2023 – Almirall, S.A. ALM) , a global biopharmaceutical company focused on skin health, today announced the publication in the British Medical Journal (BMJ) of the POSITIVE study protocol, the first clinical study in dermatology to assess patients’ wellbeing as a primary endpoint. read more
52 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
CPHI to return to Milan in 2024
European Pharmaceutical Review
AUGUST 15, 2023
“Fiera Milano is the ideal venue for a global event like CPHI, which is an important tenet of this industry and central to the world economy, with the Lombardy region being a leading producer of pharmaceuticals,” commented Roberto Foresti, deputy general manager of Fiera Milano.
Packaging 88
88 
EU launches AI-powered real-world data project for cancer therapies
pharmaphorum
NOVEMBER 25, 2022
million) in funding to a new project that aims to boost the ability of hospitals within the EU to collect real-world data (RWD) to gauge the effectiveness of novel cancer therapies. The post EU launches AI-powered real-world data project for cancer therapies appeared first on.
Hospitals 90
90 Hospitals 90
90 
Acquisition deal to back European biosimilars market
European Pharmaceutical Review
NOVEMBER 30, 2023
As we continue to drive innovation and invest in the future, our mission is singularly focused on the development, manufacturing, distribution, and commercialisation of these medicines in Europe and in the world,” affirmed Jozef Belcik, Head of Commercial Europe & JANZ, Biocon Biologics Ltd.
96 
Pharma pollution ‘threatens world environment, health’; study
pharmaphorum
FEBRUARY 15, 2022
One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study. Madrid in Spain topped the list of European samples. The post Pharma pollution ‘threatens world environment, health’; study appeared first on.
Compounding 104
104 Compounding 104
104 
The vital role of conferences in pharmacy practice: a view from EBMT
Hospital Pharmacy Europe
MAY 9, 2024
In today’s interconnected world, national and international conferences are pivotal in informing us of innovations and significant developments in patient care and clinical practice. The conference landscape in a changing world Since the Covid-19 pandemic, the world of conferences has evolved.
Hospitals 52
52 
Doctors warn pandemic has pushed lung cancer services back 20 years
pharmaphorum
JANUARY 26, 2021
Governments must act to restore the damage done to lung cancer services during the pandemic in order to reduce further avoidable deaths, according to a report drawn up as part of this week’s World Economic Forum in Davos.
Documentation 102
102 
European approval of SC atezolizumab offers quicker and more flexible cancer treatment
Hospital Pharmacy Europe
JANUARY 18, 2024
In August 2023, the NHS in England became the first health system in the world to roll out SC atezolizumab after its approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
Hospitals 101
101 Hospitals 101
101 
UK’s clinical research recovering slower than Euro peers, says ABPI
pharmaphorum
SEPTEMBER 29, 2021
The UK emerged as a major world force in COVID-19 studies, running 68 trials that positions the company third in the world rankings after the US and Brazil, although at the same time enrolment for human trials in other diseases like cancer, heart disease and diabetes slumped. Last year, more than 1.3
59 
Expanded Pluvicto production gets FDA go-ahead
European Pharmaceutical Review
JANUARY 8, 2024
Commercial manufacturing of Novartis’ radioligand therapy Pluvicto TM (INN: lutetium ( 177 Lu) vipivotide tetraxetan / USAN: lutetium Lu 177 vipivotide tetraxetan) at its largest and most advanced manufacturing facility for these treatments manufacturing in the world, has been approved the US Food and Drug Administration (FDA).
FDA 74
74 
Janssen leads effort to cut waste in digital health devices
pharmaphorum
OCTOBER 14, 2022
The four devices will be put through their paces in real-world healthcare settings via pilot projects in Norway, Belgium, Slovenia, Spain, and Germany. The project started on 1 October and is scheduled to complete in September 2026.
Labelling 124
124 Labelling 124
124 
FMF World Congress 2023: Janssen shares new data in HDFN
European Pharmaceutical Review
JUNE 27, 2023
This data was presented at the 2023 Fetal Medicine Foundation (FMF) World Congress in Spain. ” The post FMF World Congress 2023: Janssen shares new data in HDFN appeared first on European Pharmaceutical Review. In pregnancies requiring an IUT, all live-born infants required a simple transfusion.
Immunization 82
82 Immunization 82
82 
Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ & Annex 1 Conference
ISPE
JULY 28, 2023
As always, we have encouraged the local pharmaceutical industry to submit proposals for talks, and we are happy to share that there will be several local heroes presenting their projects from Catalunya and Spain. However, there will be speakers from the whole world of ISPE: from industry, from suppliers, and from regulatory bodies.
96 
Hipra’s Covid-19 booster gets EMA nod and enters an uncertain landscape
Pharmaceutical Technology
MARCH 31, 2023
Bimervax is a recombinant protein subunit vaccine, marketed by the Girona, Spain-based Hipra. Available to people ages 16 years and above who have been vaccinated with a Covid-19 mRNA vaccine, EMA’s Human Medicines Committee concluded the vaccine is ready for marketing authorization in the EU, on 30 March.
Vaccines 110
110 
Novartis taps smartpatient for app to support wet AMD patients
pharmaphorum
NOVEMBER 23, 2020
See What’s Next is available to patients through their ophthalmologists, according to smartpatient, which has co-created the wet AMD app with Novartis, and will roll out initially in Italy and Spain with additional markets planned in the coming months.
IP is no barrier to COVID vaccine access, says industry
pharmaphorum
JUNE 21, 2022
The Quad compromise, a World Health Organization plan which would, if enacted, release members from granting or enforcing COVID-19 vaccine patents, was discussed at the 12th Ministerial Conference (MC12) last week. However, there is still a huge disparity in access across the globe. That compares to just 0.1% in Burundi, 1.2%
Vaccines 95
95 Vaccines 95
95 
New Bill could enhance UK clinical trial regulation
European Pharmaceutical Review
OCTOBER 27, 2023
Comparatively, Mansfield shared that Spain has witnessed significant improvements in recent years with the introduction of legislation which mandates strict timelines for approval. Timeframes to set up trials were reduced (on average) by 15 percent within a year of the legislation coming into force.”
Join the Frontiers Health 2020 Global Hybrid Conference
pharmaphorum
NOVEMBER 2, 2020
In the last five years, the conference has turned into a unique platform for deal making, networking and learning in the industry and has been repeatedly defined as a home to the digital health ecosystem , gathering thousands of innovators, leaders and key players from the health industry each year in Berlin and in other locations across the world.
52 
First-in-class oral antibiotic improves tuberculosis
European Pharmaceutical Review
NOVEMBER 16, 2022
The trial was part of the anTBiotic project, a collaboration between GSK Global Health Medicines R&D (Spain), the University of Tromsø (Norway), Forschungszentrum Borstel (Germany), the University of Cape Town (South Africa) and the TASK Foundation (South Africa).
83 
Patient backlog caused by COVID ‘could take six years to clear’
pharmaphorum
APRIL 14, 2022
The report, commissioned by Sony Europe, polled 300 oncologists and 300 surgeons working in the UK, Germany, France, Spain, Italy and Poland. And while the use of wearable health devices has exploded in recent years, the respondents said they felt healthcare infrastructure technology is not being implemented at the same speed.
Hospitals 78
78 
COVID-19 increased demands on carers’ wellbeing, study finds
pharmaphorum
FEBRUARY 17, 2021
Countries included in the survey were the US, Canada, the UK, France, Germany, Italy, Spain, Australia, Brazil, Taiwan, India and China. The report is based on findings of an independent, third-party market research provider and non-government organisations, which interviewed more than 9,000 unpaid carers across 12 countries.
Amarin Makes Moves towards Global Expansion of Vazkepa
Pharmaceutical Technology
SEPTEMBER 22, 2022
Furthermore, this year Vazkepa has received positive recommendations from France and the Netherlands, with a positive recommendation soon to be released from Spain. The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 Cardiovascular disease landscape.
How to improve payer engagement with tailored value communication
pharmaphorum
MAY 19, 2021
In this article, Cecilie Alstad, senior analyst at Research Partnership, discusses how an approach established in the world of marketing and commercial strategy could be the key to significantly improving pharma’s payer engagement. However, value can mean different things to different payers.
Tapping into pharma’s growing opportunities in digital health
Pharmaceutical Technology
AUGUST 4, 2022
In addition to doing more to proactively support healthcare providers and patients, digital health opportunities provide a chance for pharma companies to capture (and become a trusted source of) important real-world data about patients’ behaviour and their wider wellbeing. He is also an adjunct professor at Madrid’s IE University in Spain.
Hospitals 143
143 Hospitals 143
143 
Almirall kicks off another hunt for skin disease therapy partnerships
pharmaphorum
JULY 5, 2021
The call “is addressed to scientists affiliated to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world,” according to the drugmaker.
A year on: pandemic driven trends in HCP engagement
pharmaphorum
MAY 10, 2021
Spain and the US are the only countries yet to see recovery to where they were a year ago, whilst Germany and Japan have actually increased to levels above where they were pre-pandemic. In Spain, other channels went from 12% of total activity in January 2020, to 94% in May and back to 62% in March 2021.
Hospitals 76
76 Hospitals 76
76 
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
pharmaphorum
OCTOBER 16, 2020
The results from the World Health Organization’s large Solidarity trial are yet to be peer reviewed but were posted online on a preprint server. Gilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in a large global trial, casting doubt on previous supportive study findings.
Hospitals 76
76 
Government needs strategy to kick-start R&D after COVID, says pharma body
pharmaphorum
OCTOBER 8, 2020
In its second annual report on the state of UK clinical trials, the ABPI compared how the UK performed against other countries in Europe and other influential countries around the world. In phase 3, the UK ranked third in Europe behind Germany and Spain and was fourth globally behind the US.
Immunization 59
59 
Risk-sharing agreements are growing at a rate of 24%
Pharmaceutical Technology
FEBRUARY 10, 2023
million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world. Their widespread agreements are established in the UK, followed by seven additional countries (Australia, France, Netherlands, Spain, Poland, Italy, and Canada). This is not the first treatment to come with a high price tag.
FDA 105
105 FDA 105
105 
How eligible patient numbers affect price of rare disease drugs in France
pharmaphorum
DECEMBER 7, 2022
In accordance with previous findings across EU5 (France, Germany, Italy, Spain, and the UK) and Japan, CRA analysis shows a correlation between reimbursed ATC and eligible patient number (an indication of disease prevalence) in France, in which ATC decreases as eligible patient number increases (as shown in Figure 1a).
99 
Vulnerable should all get COVID-19 shot before summer, says NHS chief
pharmaphorum
DECEMBER 29, 2020
At the same time, the new, more transmissible variant of SARS-CoV-2 that was first identified in the UK has been detected in more than 20 other countries around the world, including several EU member states, India, Canada, Japan and Hong Kong. So far there is little evidence of “ anti-vaxxer ” resistance to the vaccine in the UK.
Vaccines 104
104 
Message from the Chair: Why Attend the 2023 ISPE Pharma 4.0™ & Aseptic Conference
ISPE
JULY 28, 2023
As always, we have encouraged the local pharmaceutical industry to submit proposals for talks, and we are happy to share that there will be several local heroes presenting their projects from Catalunya and Spain. However, there will be speakers from the whole world of ISPE: from industry, from suppliers, and from regulatory bodies.
98 
ABPI warns against revenue clawback rate rises
European Pharmaceutical Review
FEBRUARY 3, 2023
Compared to other leading EU countries (Italy, Spain, Germany, France), the UK has experienced the largest decline in its global share of new medicine launches between 2016-2021. The ABPI emphasised that recent Government policy has led to disinvestment in medicines through the cap on growth for a decade.
Vaccines 59
59 Vaccines 59
59 
First monkeypox deaths outside Africa recorded
pharmaphorum
AUGUST 1, 2022
Monkeypox has claimed the first lives outside Africa – one in Brazil and another two in Spain – although the World Health organization (WHO) has said the outbreak remains “containable.”
Vaccines 52
52 
Chasing rivals, AbbVie files migraine prevention drug atogepant in EU
pharmaphorum
JULY 18, 2022
The market research group recently predicted Vydura and atogepant will achieve sales of $35 million and $57 million, respectively, by 2030 in the five major European markets of France, Germany, Italy, Spain, and the UK. GlobalData has said it expects Qulipta to get approval for chronic migraine prevention in 2023, helping it to sales of $1.2
FDA 52
52 FDA 52
52 
PCSK9 inhibitor persistence high in patients with FH
Hospital Pharmacy Europe
DECEMBER 11, 2022
In the current study, researchers set out to examine the persistence to treatment, efficacy and impact on quality of life of PCSK9 inhibitor use in FH patients within a real-world clinical setting.
Hospitals 52
52 Hospitals 52
52 
Osteoporosis treatment options – down to the bare bones
pharmaphorum
OCTOBER 13, 2022
It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025.
States halting AZ jab a ‘disaster’ for EU’s COVID vaccination programme
pharmaphorum
MARCH 16, 2021
Germany, France, Italy and Spain are among the member states that have announced a suspension of dosing with AZD1222 in the last 24 hours as investigations into blood clots seen in 37 out of around 17 million people who have received the jab are investigated.
Vaccines 98
98 
Moderna ramps up EU COVID jab capacity via Lonza deal
pharmaphorum
JUNE 2, 2021
Since then, it has also announced a new production line at ROVI in Granada, Spain, that should also come online this year and help the company meet its objective of being able to make 3 billion doses in 2022, up from 800 million to 1 billion doses this year. Pfizer and BioNTech filed for FDA approval of their COVID-19 vaccine on 7 May.
Vaccines 52
52 
Long-acting antibody demonstrates promising efficacy in infant RSV
European Pharmaceutical Review
MAY 2, 2024
These findings, from the first RSV season after introduction of Beyfortus, are part of NIRSE-GAL , a three-year follow-up study in Galicia, Spain. Additionally, a study from Catalonia, Spain, pre-printed in The Lancet showed reductions of 87.6 percent and 90.1
Hospitals 104
104 
Top tweets: Covid-19 headed towards seasonality – and more
Pharmaceutical Technology
JULY 22, 2022
The World Health Organization (WHO) further stated that at least 18 of the children underwent liver transplants, and one had died. Helen Branswell, an infectious diseases and health reporter at the news website Stat News, shared an article on a monkeypox case being reported in the US, amid rising cases in Spain, Portugal, and Europe.
Vaccines 52
52 
Annex 1 in Force! Join the First Discussion after the 25 August Effective Date
ISPE
SEPTEMBER 21, 2023
Amanda Gilabert, a seasoned professional with over a decade in the industry, brings real-world experiences to the forefront in her discussion on the Aseptic Fill Finish of Soft Mist Inhaler.
At ESMO 2022, oncologists saw exciting cancer advances
pharmaphorum
OCTOBER 20, 2022
In a report from life science market insights firm, InCrowd , medical oncologists and haematology oncologists from the UK, France, Germany, Italy, and Spain named three tumour tracks as the most exciting areas to be discussed. About the author. For a copy of the ESMO 2022 report please click here.
52 
Let's personalize your content